The present invention relates to novel anti-CD73 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules； to methods for preparing such antibody molecules； to host cells expressing or capable of expressing such antibody molecules； to compositions comprising such antibody molecules； and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
